EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis

Huanli Jiao, Han Wang, Jia Li, Ziyi Yang, Chao Sun

Seminars in Liver Disease · 01.09.2025 · 45 (03) · 303-314

DOI: 10.1055/a-2564-7551 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.09.2025. Verfasst von Huanli Jiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management, Tianjin Hospital, Hexi District, Tianjin, People's Republic of China. Hauptthemen laut MEDLINE: Sarcopenia, Liver Cirrhosis, Frailty, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 102 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cirrhosis is an important cause of morbidity and death in patients with chronic liver disease. It can be divided into compensatory and decompensated stages. During the decompensation period, complications such as esophageal and gastric varices hemorrhage, hepatic encephalopathy, infection, and hepatorenal syndrome are often incurred, which has a high mortality rate and leverages huge economic burden on society, healthcare resources, and individuals. Sarcopenia and frailty are common in patients with cirrhosis. The pathogenesis of sarcopenia and frailty in the context of cirrhosis is complicated and multifactorial, including overwhelming systemic inflammation, imbalance of muscle protein metabolism, malnutrition, endocrine and metabolic dysfunctions, intestinal microecological disorders, lack of physical exercise, and other aspects. Notably, accumulating evidence implicates that many patients experience sarcopenia/frailty even before the onset of liver cirrhosis. In this regard, the magnitude of liver fibrosis is closely linked to the progression of sarcopenia with reciprocal impact. In conclusion, this review article will shed light on the pathogenesis of cirrhosis complicated with sarcopenia/frailty, aimed at facilitating early diagnosis and effective management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaLiver CirrhosisFrailtyMuscle, SkeletalHumansRisk Factors

Autor:innen und Institutionen

  • Department of Health Management, Tianjin Hospital, Hexi District, Tianjin, People's Republic of China.
  • Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
  • Department of Gastroenterology, Tianjin Medical University General Hospital Airport Hospital, Tianjin, People's Republic of China.

Zitieren

APA

Jiao, H., Wang, H., Li, J., Yang, Z., & Sun, C. (2025). The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis. Seminars in Liver Disease, 45(03), 303-314. https://doi.org/10.1055/a-2564-7551

Vancouver

Jiao H, Wang H, Li J, Yang Z, Sun C. The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis. Seminars in Liver Disease. 2025;45(03):303-314. doi:10.1055/a-2564-7551

BibTeX
@article{Jiao2025,
  author = {Jiao, Huanli and Wang, Han and Li, Jia and Yang, Ziyi and Sun, Chao},
  title = {The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis},
  journal = {Seminars in Liver Disease},
  year = {2025},
  volume = {45},
  number = {03},
  pages = {303--314},
  doi = {10.1055/a-2564-7551}
}
Kostenlos starten →